(Last updated : 2025-09-05 12:21:53)
  Toru Oga
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of Respiratory Medicine,
   Position   Professor
■ Present specialized field
COPD, asthma, sleep medicine, respiratory failure, patient-reported outcome 
■ BooK
1. 2022/02/02   Clinical Cases in Noninvasive Ventilation in Quality of Life., Teaching Pearls in Noninvasive Mechanical Ventilation 
2. 2014/01/20   Longitudinal Changed in Dyspnea, DYSPNEA: Mechanisms, Measurement, and Management Therd Edition 
■ Journal
1. 2025/09 Current status and regional differences in disaster planning and preparedness for home oxygen therapy: Insights of the Japanese White Paper on Home Respiratory Care 2024. 
2. 2025/09 Short-acting β2 Agonist Inhalation Therapy for Asthma or Chronic Obstructive Pulmonary Disease with a High-flow Nasal Cannula in Japan - An Online Questionnaire Survey by the Japanese Respiratory Society, Japanese Society of Intensive Care Medicine, and Japanese Society of Respiratory Care Medicine. 
3. 2025/08 Fluorescein Angiography May Predict Surgical Outcomes of Tractional Retinal Detachment in Familial Exudative Vitreoretinopathy. 
4. 2025/07 Clinical features in four patients with syphilitic outer retinopathy. 
5. 2025/06/28 Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer  Link
Display all(186)
■ Presentation
1. 2025/04/28 XAGE1 cancer-testis antigen is a diagnostic marker and therapeutic target in lung adenocarcinomas. (Poster notice,General) 
2. 2024/12/03 Hyaluronic acid enhances the effect of allergen-specific sublingual immunotherapy in a mouse model of mite-induced chronic asthma (Poster notice,General) 
3. 2024/09/09 Serum NY-ESO-1 and XAGE1 antibodies are diagnostic and cancer-specific immunomonitoring markers in NSCLC (Poster notice,General) 
4. 2024/05/15 Serum NY-ESO-1 and XAGE1 antibodies are potentially predictive and immunomonitoring markers of response to immune checkpoint therapy in non-small cell lung cancer (Speech,General) 
5. 2023/09/20 Antibodies against tumor-associated antigens are associated with response to immune checkpoint therapy for non-small-cell lung cancer (Poster notice,General) 
Display all(10)
■ Belonging society
1. American Thoracic Society
2. European Respiratory Society